Remove 2025 Remove Investment Banking Remove Public Trading
article thumbnail

Data Analytics M&A and Market Update 1H 2024

Solganick & Co.

It covers the latest M&A transactions, provides a data analytics market map, updates on industry size and growth data, and publicly traded companies and valuations in the sector. June 2, 2024 – Solganick & Co. has published its latest mergers and acquisitions (M&A) and market update and report on the data analytics sector.

M&A 52
article thumbnail

Technology Services Mergers Update – Q1 2024

Solganick & Co.

Solganick is a data-driven investment bank that specializes in IT services and software companies and has advised on multiple M&A transactions within the covered sector verticals. Solganick expects M&A deals to increase in the technology services sector for the remainder of 2024 and continuing into 2025.

Mergers 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Single Store Generalist Shops | Why the Era is Coming to an End with Cole Strandberg

Focus Investment Banking

I hope 2024 treated you and yours incredibly well, and I’m looking forward to an even better year in 2025. The focus of the collision vision in 2025 is to double down on the most important and timely topics in the collision repair business and to triple or even quadruple down on offering actionable insights for your business.

article thumbnail

Single Store Generalist Collision Repair Shops are Going Extinct — But That Could Be a Good Thing

Focus Investment Banking

After college and a foray into investment banking, Strandberg joined the family business, and remained with it after it was acquired by a private equity group. About three years ago, he joined FOCUS Investment Banking , where he works on mergers and acquisitions and raising capital within the collision repair industry.

article thumbnail

2025 Could Be the Year of the Retina Practice Deal

Focus Investment Banking

Cencora, one of the largest publicly-traded pharmaceutical companies in the world, distributes pharmaceuticals, over-the-counter healthcare products and other healthcare supplies and equipment to healthcare providers. The post 2025 Could Be the Year of the Retina Practice Deal appeared first on FOCUS.

article thumbnail

Momentum Builds for Ophthalmology Recapitalizations

Focus Investment Banking

Traditional terminal exit routes for private equity-backed companies are to larger strategic acquirers (often public companies) and IPOs, where a private company becomes publicly traded. However, the type of larger company that would be interested in buying physician practice management (PPM) companies has been unknown.